SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " BIO " 2,833 found 🔀 AI-powered Shuffle
Do You Really Need AI to Track Your Poop?
Influencers are putting biotrackers in their toilets.
MD lawmaker's historic journey unfolds in book that's part autobiography, part political memoir
Maryland lawmaker, Lily Qi, writes about her journey from China to the US and into state politics in a book that's part autobiography, part political memoir
Android 17's new lock screen trick could frustrate anyone trying to break into your phone
Google has detailed how Android 17 implements tougher lock screen security by drastically reducing PIN guess attempts and more.
5 takeaways from Anthropic’s big science event
The company rolled out a biology-centric version of Claude and hosted surprisingly forthright conversations about AI and science.
Children’s Hospital Los Angeles’ 2026 TSRI Science Day Highlights Advances in Cancer Biology
June 17 saw more than 400 scientists, clinicians, research staff, and other Children’s Hospital Los Angeles team members come together for The Saban Research Institute’s (TSRI) yearly symposium and poster session—Science Day 2026.
Scrolling for science: How a Twitter post discovered a new wasp in Fukuoka, Japan
Researchers at Kyushu University recently identified a wasp species, Eupelmus curvator, in Japan for the first time after citizen scientists posted photos of it on Twitter (now X), marking both a new national record and the first formal description of the male of the species. The discovery highlights the growing role of social media in biodiversity research, allowing scientists to tap into observations from the public that would otherwise go unnoticed.
Wilmington Small Business Coalition: Building Momentum in 2026 by Heather McWhorter
This article was contributed by Lydia Thomas, UNCW CIE Program Manager. North Carolina continues to be one of the best states to start a business and in 2025, Wilmington, North Carolina earned a spot on the GoDaddy list of the top 10 most entrepreneurial cities in the U.S. While many know Wilmington as small beach town with exceptional food, lots of coffee shops, and fun, vibrant summer activities, a closer look reveals a thriving innovation economy. You’ll find startups emerging across industries including software, healthtech, bluetech, and fintech. At the core of this entrepreneurial ecosystem is the Wilmington Small Business Coalition, with small business advocates and entrepreneur support organizations (ESOs) dedicated to helping founders grow, thrive, and succeed. “No Wrong Door” Established in 2016, the Coalition was designed to make it easier for individuals and small businesses to access resources most suited to their particular needs. The Coalition is designed to have a “no wrong door” entryway into the regional startup ecosystem. Whether you are exploring a new idea sketched on the back of a napkin or leading a more established, growth-stage company, Coalition members can help connect you with the programs, funding opportunities, mentors, and resources best suited to your needs. No matter where you are in your entrepreneurial journey, any Coalition organization can help point you in the right direction. Coalition Members and Leadership Coalition members include the UNCW Center for Innovation and Entrepreneurship (UNCW CIE), AARP, Brunswick Community College Small Business Center, Cape Fear Community College Small Business Center, Cape Fear Region SCORE, Genesis Block Foundation, Network for Entrepreneurs in Wilmington (NEW), Small Business & Technology Development Center (SBTDC), Greater Wilmington Chamber of Commerce, YWCA Living the Dream Center for Entrepreneurship, Carolina Community Impact Fund (CCI Fund), Partner Community Capital, 717mkt Office Collaborative, NC Biotech, and Institute NC. In May 2026, the Coalition held its leadership elections, resulting in the selection of a new executive team. The following officers were elected to serve two-year terms: Chair: Lydia Thomas, UNCW CIE Vice Chair: Diane Lantz, CCI Fund Secretary: Aariene Hansley, Genesis Block Foundation Treasurer: Gloria Monroe, SBTDC Vision for the Wilmington Small Business Coalition In 2026, the Wilmington Small Business Coalition continues its work as a collaborative network of organizations. By connecting programs, expertise, and services across partner organizations, entrepreneurs can more easily find the right support at the right time. Rather than operating in silos, the Coalition aims to function as a unified, cohesive system of support for small businesses and entrepreneurs, ensuring that resources and expertise across partner organizations are visible and accessible. Through stronger collaboration and shared pathways, entrepreneurs can move more seamlessly from idea to startup to growth. Looking to dive into the Wilmington entrepreneurial ecosystem? Connect with any of the Coalition partners to get started! Connect with CIE To learn more about CIE and our services, programs, and events, join the CIE newsletter. You can also follow us on social media: Instagram, Facebook, LinkedIn, TikTok, or YouTube. CIE’s website is uncw.edu/cie. Heather McWhorter is the director of the UNCW Center for Innovation and Entrepreneurship (CIE). CIE supports innovation-forward start-ups and helps to build a vibrant innovation economy for all in southeast NC.
Anthropic's New AI Workbench Mapped My Field For $26. Now Imagine It Aimed At The Rest Of Science
Anthropic's Claude Science is a capable AI research workbench built for molecular biology. The opportunities for the rest of science are enormous.
Claude Science is Here, Antibiotics Designed by Text Prompt Among Applications
Basecamp Research’s antibiotic design and vaccine prediction AI models are now available through Anthropic’s Claude Science.
New BioShocking attack manipulates AI browser into data theft
A new prompt injection attack dubbed "BioShocking" could trick AI-powered browsers into treating real-world risky actions as part of a fictional scenario, causing them to ignore any safety guardrails.
Kelly statement on SCOTUS ruling protecting girls' and women's sports
WASHINGTON, D.C. -- Today, following the U.S. Supreme Court's decision to prevent biological men from playing in girls' and women's sports, U.S. Representative Mike Kelly (R-PA) released the following statement:
Recent Research on How Experiencing Racial Discrimination Impacts Health
This brief provides an overview of the relationship between racial discrimination and health and highlights research examining mechanisms underlying health outcomes linked to experiences of racial discrimination, including biological changes, chronic stress, mental health, substance use, pregnancy-related outcomes, and sleep.
Anthropic debuts Claude Science, an AI product for bioscience
On Tuesday, Anthropic announced Claude Science, a new product that company leaders describe as an AI workbench for scientific research.
The invasive fern that science misidentified for decades
Salvinia molesta can double its biomass in 36 hours. It spreads across ponds, lakes and slow-moving waterways in a smothering green mat, blocking sunlight, consuming oxygen and collapsing the ecosystems ...
Basecamp Research brings EDEN's antibiotic and vaccine design models to Claude Science
/PRNewswire/ -- Basecamp Research today announced that its antibiotic design and vaccine target prediction EDEN models are now available through Claude,...
Molecular imaging pioneer Eva Nogales awarded the 2026 Vanderbilt Prize in Biomedical Science
The Vanderbilt Prize in Biomedical Science recognizes scientists who have a stellar record of research accomplishments.
SCOTUS protects girls in sports, upholds biological reality
A trans athlete keeps winning girls' state titles in California. The Supreme Court just made sure 27 other states don't have to allow it.
Supreme Court makes ruling on trans athletes in women's sports
The U.S. Supreme Court ruled 6-3 to uphold West Virginia and Idaho laws requiring student-athletes to compete based on biological sex at birth.
New BioShocking Attack Tricks AI Browsers Into Leaking User Credentials
LayerX says BioShocking used indirect prompt injection to trick six AI browsers into copying credentials from signed-in accounts.
Biology alumni receive honor for undergraduate paleontology research
Julia Zottola ’26 and Sofia Corsico-Sánchez ’26 earn recognition from the Association for Women Geoscientists and the Paleontological Society
Gaining biological insights through supervised data visualization
Nature Computational Science - This study introduces RF-PHATE, a supervised visualization method that preserves data structure while revealing biological patterns, enabling insights into disease...
Indy economic development leaders visiting Switzerland on trade trip
The trip will involve meetings with leaders in the life sciences, biotechnology and pharmaceuticals, medical technology, digital heath and advanced manufacturing sectors.
Faculty in Politics, Chemistry, Biology and English Appointed to Endowed Professorships | Pomona College in Claremont, California
Four faculty members have been awarded endowed professorship positions. The Pomona College Board of Trustees voted to support these appointments during their meeting in May.
Hood College Launches Accelerated One-Year Master of Science in Environmental Biology Track
Beginning in Fall 2026, Hood College's Graduate School will offer a new accelerated, 30-credit track within its Master of Science in Environmental Biology program, providing students with a pathway to earn their degree in just one academic year while gaining valuable hands-on research experience.
Israeli health-tech conference opens in Jerusalem with 1,800 participants from 40 countries
MIXiii Health-Tech.IL 2026 brought together investors, doctors, researchers, startups and global health-tech leaders, with a focus on Israeli emergency medicine, tech-bio, and technologies.
Databricks and Nvidia Launch Genesis Workbench for AI Scientists
AI is becoming an increasingly important tool for drug discovery. However, for many pharmaceutical and biotech companies, the challenge isn’t finding more powerful models. It’s getting existing models to work […]
Why scientists fear we're missing evidence of extraterrestrial life
Scientists are raising concerns that we may be overlooking evidence of extraterrestrial life even when it is present. Hidden biosignatures, limitations in detection technology, and assumptions about what life should look like can all create dangerous false negatives. The researchers say future missions should focus not only on finding life, but also on understanding how signs of life could be missed.
Careers That Shaped Biology
Every great scientific career begins with a question no one has been able to answer — and a scientist stubborn enough to keep asking it. This series looks back at the careers of some of HHMI’s most distinguished scientists — people whose contributions have changed what we know about life itself, and whose stories reflect the best of what science, and scientists, can be.
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases
Oversubscribed $225 million concurrent private investment in public equity ("PIPE") with available cash to the combined company at closing anticipated to fund...
Investor Clive Meanwell on designing biotechs for population health, and AI's role as a catalyst
Clive Meanwell, chairman of investment firm Population Health Partners, was an AI skeptic until recently. Now, he thinks it's a catalyst.
Ingredion plans global Benicaros prebiotic expansion across gut and immune health applications
Ingredion highlights that its recent acquisition of the Benicaros prebiotic is a strong strategic addition to its Healthful Solutions portfolio, supporting the company’s formulation versatility alongside expansion of health-forward and clean label ingredients. The company purchased the patented prebiotic fiber, made from upcycled carrot pomace, from NutriLeads earlier this month. With the deal, Ingredion obtained full ownership of all intellectual property, trademarks, human clinical trials, and know-how related to manufacturing Benicaros.
This Ochsner Health “intrapreneur” has tips for innovating in-house
Korak Sarkar, MD, MHDS, leads a biodesign lab at Ochsner Health and details how physicians can pursue innovation from within their organizations.
AI scientist company Edison Scientific tapped by team behind Metsera to create new biotechs
Edison Scientific and investment firm Population Health Partners are teaming up to leverage AI agents in drug discovery and development.
America's lifespan has doubled since 1776
U.S. life expectancy has doubled since 1776 thanks to vaccines, antibiotics, sanitation and clean water that reduced infectious disease deaths.
Life Science Reagent Market Forecast Points Higher Toward 2035, Driven by Biopharma Scale-Up and Cell Therapy Expansion
World life science reagent market forecast 2026-2035: CAGR 6-8%, index 2035=185. Bioprocessing, cell therapy, and QC drive growth. Key players: Thermo Fisher, Merck, Danaher.
Caldwell University Professors Join Nationwide "Phage Hunters" Science Alliance
Caldwell, NJ – Three professors of Caldwell University’s Department of Natural Sciences, Dr. Maria Agapito, Dr. Darryl Aucoin, and Dr. Hector Loyola Irizarry, attended the Howard Hughes Medical Institute (HHMI) […]
Reports: Diomande agrees PSG move from Leipzig
Ivory Coast forward Yan Diomande has decided to leave RB Leipzig for Paris Saint-Germain, according to media reports. Broadcasters Sky and RMC, as well as transfer specialist Fabrizio Romano, reported on Sunday that the 19-year-old has agreed a five-year contract with the French Champions League winners.
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to
Reproduction affects health—and so does biological sex
Starting one's sex life and having children at a young age can run in the family. But can pregnancy have beneficial health effects, and do the partner's genes contribute to them? "We are just beginning ...
These tiny soil microbes could rescue crops from salty farmland
Researchers have discovered that beneficial soil bacteria give plants an unexpected survival advantage in salty soils. Instead of helping plants keep salt out, the microbes stimulate the production of lignin, a natural compound that strengthens roots and makes plants more resilient. Greenhouse and field tests showed healthier plants and higher yields in salty conditions. The findings could lead to bio-based treatments that help farmers grow crops on land once considered too salty for agriculture.
Rise in cancer in younger adults may be explained by faster 'biological aging,' early study hints
Researchers report that younger adults with older‑than‑expected biological ages are more likely to develop early‑onset lung, gastrointestinal and uterine cancers, but more research is needed.
Vikas Sehdev: Starting a New Chapter as Senior Medical Science Liaison at BioNTech SE
Vikas Sehdev: Starting a New Chapter as Senior Medical Science Liaison at BioNTech SE / AstraZeneca, BioNTech SE, cancer, OncoDaily, Oncology, Vikas Sehdev
Could 'humanmaxxing' actually help you live longer? Here's what experts say
Humanmaxxing is the latest wellness trend focused on maximizing human potential through biohacking, longevity science and advanced medical treatments.
Could 'humanmaxxing' actually help you live longer? Here's what experts say
Humanmaxxing is the latest wellness trend focused on maximizing human potential through biohacking, longevity science and advanced medical treatments.
Scientists Challenge a Fundamental Assumption About Consciousness
A new philosophical study challenges the idea that consciousness requires human-like biology.
Colorado microbiome expert shares ways to improve gut health
Mountain lions changed everything in this tiny California preserve
A surprising ecological makeover unfolded when mountain lions began frequenting a small preserve south of San Francisco. Deer activity dropped, plants recovered, and shifts among predators like coyotes, bobcats, and foxes followed. The study shows that powerful “trophic cascades” aren’t limited to remote wilderness—they can happen in small, suburban preserves too.
Scientists discover what triggers belly fat as we age
Aging may trigger the appearance of specialized stem cells that supercharge the body's ability to create new belly fat. The discovery reveals a potential biological driver of middle-age weight gain and a promising target for future anti-obesity treatments.
Marine biobanks: the science of 'stopping time' for an ecosystem under pressure
In labs around the world, the ocean is being kept in jars. Some of it is alive, bubbling in flasks, while some lies frozen in liquid nitrogen. These marine biobanks are collections of coral cells, algae,…
Pro-Israel influencers criticize Vance, but evangelicals remain open to him
Despite attacks from some conservatives, a heavily pro-Israel crowd still has warm words for Vance, with many saying they could pick him as the party’s nominee.
Scientists infected a 'vagina on a chip' with gonorrhea — then cured it with a new antibiotic found by AI
To sift through 6 million molecules in pursuit of new gonorrhea treatments, researchers trained AI to select the best drug candidate and then tested it in a "vagina on a chip."
Why Do Deadly Viruses Spare Mosquitoes? Science Has an Answer
Mosquitoes carry some of the world's deadliest viruses, biting victim after victim for their entire lives without ever getting sick themselves. Scientists have long suspected a biological explanation,...
Scientists stunned by signs of ancient life in a place no one expected
Scientists exploring ancient seafloor rocks in Morocco discovered mysterious wrinkle patterns where they were never expected to occur. These structures are normally linked to microbial mats in shallow, sunlit waters, yet the rocks formed hundreds of feet below the surface in darkness. Evidence indicates that chemosynthetic microbes created the wrinkles, revealing that deep-ocean microbial ecosystems may have been more widespread than previously thought.
AI Assistant Tool QED Scores bioRxiv Preprint Quality
QED, an AI assistant tool, evaluates the originality and validity of bioRxiv preprints, assigning them QED Scores. Researchers report that its rankings often align with expert opinion.
Priscilla Chan on science, disease prevention and the future of medicine
CNBC's Becky Quick sits down for a conversation with Dr. Priscilla Chan, co-founder of Biohub, at Aspen Ideas: Health.
Democratic socialists’ battleground test: From the Politics Desk
Plus, Pete Buttigieg is back on the campaign trail. And digging into Michael Whatley’s bio in the North Carolina Senate race.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Merck KGaA to Acquire Bio-Techne for $11.3B, Expanding Life Science Tools Presence
Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life science value chain by expanding its presence in high-growth, next-generation life-sci markets with Bio-Techne’s tools, analytical technologies, and consumables.
Bio-Techne, a Minneapolis life sciences firm with 500,000 products, to be sold to German company for $11.3 billion
UT Health San Antonio identifies the first potential probiotic treatment for lupus
Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, June 25, 2026 – Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, found a link between a bacterium in the gut microbiome, or ecosystem, and lupus, which could lead to more effective […]
Finding Strength Through Sports While Living with Phenylketonuria
Episode 3 explores how teens with PKU balance the demands and realities of athletics while managing this metabolic condition.
Rubio’s spin on the Iran MOU sounds different from Trump and Vance
For more than a week, America’s top diplomat was conspicuously quiet about something that would have seemed very much in his wheelhouse: a nascent agreement with Iran. But now Secretary of State Marco Rubio is speaking.
Merck KGaA bolsters life sciences business with $11.3B Bio-Techne buy
The deal comes a matter of weeks after Kai Beckmann was promoted to CEO at Merck and signalled his intent to broaden the company's scope for M&A.
Poor metabolic health can age the brain even in young people, finds new large-scale study
Two people of very different ages can have a similar level of biological aging in their brains. Such an occurrence is possible because aging and metabolic health follow two distinct pathways that influence ...
Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion
The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.
Regenerative Agriculture and Population Health
Regenerative agriculture can enhance food quality and reduce harmful exposures through improved soil biology, biodiversity, and ecosystem health, yielding downstream benefits for agriculture, food systems, and human health. It may improve profitability through greater land resilience and lower input costs and may deliver benefits to farms, farmers, communities, and the broader environment. More research is warranted to understand the full range of potential health benefits of regenerative agriculture.
Merck Expands Life Science Leadership with Planned $11.3 Billion Bio-Techne Acquisition
Merck Expands Life Science Leadership with Planned $11.3 Billion Bio-Techne Acquisition
Germany's Merck to buy Bio-Techne for $11.3 billion
Merck KGaA has agreed to acquire biotech firm Bio-Techne for $11.3 billion, the German science and healthcare firm said in a statement on Thursday.
Germany's Merck to buy Bio-Techne for $73 per share
Merck KGaA has agreed to acquire biotech firm Bio-Techne Corp for $73 per share in cash, the German science and healthcare firm said in a statement on Thursday.
Germany’s Merck to Buy Bio-Techne for $11 Billion
Merck KGaA offered $73 a share in cash to buy Bio-Techne, representing a 24% premium to the U.S. lab-tools supplier’s closing price Wednesday.
Rubio reassures Gulf allies as US-Iran talks advance
Tehran has already portrayed the deal as a victory
The history behind the Marcus Alert System
Marcus-David Peters was a 24-year-old high school biology teacher at Essex High School when he died.
Student From Des Plaines Wins National Science Foundation Award
Elmhurst University biochemistry major Hannah Cardenas, of Des Plaines, recently received a National Science Foundation Research Experiences for Undergraduates (NSF REU) award to participate in a 10-week summer research internship at the University of Texas at Dallas.
The biotech founder asking why good science gets stuck
As an undergraduate, Alinta Furnell led student societies, pitched startup ideas and built biotechnology ventures. Now, the UNSW alumna is investigating one of innovation’s biggest challenges – why so many scientific breakthroughs never make it beyond the lab.
Mercy Helps Position St. Louis as Global Gateway for Healthcare Innovation
Mercy continues to bring innovative thought leadership to the communities it serves and beyond. Dr. Damon Broyles, Mercy vice president of clinical innovation, informatics and precision medicine, recently shared insights and helped attract new companies to St. Louis’ nationally recognized healthcare industry as part of BioSTL.
Scientists design 'tunable' biomolecules to probe how sugars behave
Sugars are not just a source of energy—they also play a crucial role in how cells communicate, how proteins interact and how materials behave in medicine and industry. But studying these processes is ...
Giant viruses discovered on Greenland ice sheet may slow glacial melting - Futura-Sciences
Giant viruses defy microbiological norms Lead author Laura Perini and her team at the Department of Environmental Science at Aarhus University identified the microorganisms during a field survey of Arctic ice. Measuring up to 2.5 micrometers in length, these viral specimens are roughly 125 times larger than conventional viral strains....
Top supplements Americans use are shifting from multivitamins to targeted health fixes
Dietary supplements are an excellent way to fill gaps in our nutritional requirements. From vitamins and macronutrients to gut-health probiotics, dietary supplements have helped people address deficiencies. ...
QED Science Launches AI Infrastructure for Scientific Validation
Recognizes The 1% After Blind Evaluation of 57,455 Scientific PreprintsTEL AVIV, Israel, June 24, 2026 (GLOBE NEWSWIRE) -- QED Science, a science validity engine and modern infrastructure for researchers, funders, institutions and life science organizations today launched The 1%, the top 574 life science preprints. The company anonymously scored 57,455 bioRxiv preprints submitted between May 2025 and April 2026 for originality and validity. The ranking is powered by QED Score, QED Science’s vali
This startup is using AI to close gaps in women’s healthcare
Xella Health’s precision health platform combines biomarker testing, clinical guidance, and AI analysis to help women get earlier answers about hard-to-diagnose conditions.
Venetian exec talks luxury meeting space and the future of conventions
Venetian Chief Sales Officer Tony Yousfi shares what drove renovations at the Convention and Expo Center and the innovations he believes will define the next era of conventions at the Strip resort.
The universe may be hiding conscious minds stranger than we can imagine
What if consciousness isn’t limited to brains like ours? Philosophers Eric Schwitzgebel and Jeremy Pober argue that consciousness could arise in many different forms of life, even in beings built from radically different materials than those found on Earth. Drawing on the vastness of the universe and the likely existence of countless alien civilizations, they suggest it would be surprisingly Earth-centric to assume that only Earth-like biology can support conscious experience.
A staunch voice in support of science
Jeff Coller, a pioneering RNA biologist, has spent the past year vehemently advocating for the lifesaving promise of research in the face of federal cuts
France confirms first Ebola case in doctor returning from DR Congo
The patient is in isolation, following strict biosafety protocols to prevent risk of spread in France.
Flagship Pioneering and Lean Business Services Company Announce Collaboration to Advance Healthcare Innovation and AI-Enabled Biomedical Research in Saudi Arabia
/PRNewswire/ -- Flagship Pioneering, the scientific innovation company behind Moderna, Generate Biomedicines, and more than 100 other life sciences ventures,...
From collagen to creatine, shop 10 Amazon supplement deals worth buying
Discover the best Amazon Prime Day supplement deals, including discounts on fish oil, collagen, probiotics and more—save up to 33% today.
Why the Madonna biopic starring Julia Garner isn't happening after all
Through the process of writing the script, Madonna was bitten by the memoir bug, and she channeled that energy into her forthcoming album "Confessions on a Dance Floor: Part II," which drops July 3.
Science Will Not Save the Abortion Pill : The Hastings Center for Bioethics
The facts are not enough. In addition to using evidence, people who support the legal right to abortion must make the moral case for it.
Nvidia Unveils Science Reasoning AI Suite with BioNeMo Agent Toolkit
The toolkit has applications across generative chemistry, genomic analysis, protein design, and biomarker discovery.
A heartfelt and emotional ‘Tick, Tick... Boom!’ from Triune Entertainment
Jonathan Larson’s autobiographical musical is performed with a wonderful blend of harmonies in the ensemble numbers.
Brooklyn College Names New Dean for the Murray Koppelman School of Business
Shalei V. K. Simms, Ph.D., appointed to lead Brooklyn’s only AACSB-accredited business school.
Offworld Space Biology: Setting Up The Life Science Glovebox
Bioengineering cartilage tissues and manufacturing advanced materials kicked off the week aboard the International Space Station
Master’s Program Revamped to Address Informatics Needs
The Master of Science in Biomedical Informatics program — previously known as the Master of Science in Health and Biomedical Informatics — will launch in the fall offering two tracks: one in bioinformatics and another in health informatics.
Pivot Fellow Natasha Blitvic Brings Math to Marine Microbiology
Pivot Fellow Natasha Blitvic Brings Math to Marine Microbiology on Simons Foundation
9 Fruits With the Most Prebiotics For Better Gut Health
Prebiotics are a type of fiber that feeds the good bacteria in your gut, supporting better digestion and overall health. These fruits are a tasty way to get more prebiotics.
Behind this “ordinary snake,” scientists stunned by a hidden new species - Futura-Sciences
A Mysterious Snake Revealed Researchers from the Chengdu Institute of Biology, partnering with the Giant Panda National Park, have officially described a new species of tree viper: Trimeresurus lii, affectionately dubbed the Huaxi green viper. The discovery was made in early 2025 and published in the open-access journal Zoosystematics and...
Build an AI Scientist for Life Science Discovery with NVIDIA BioNeMo Agent Toolkit
AI scientists are emerging as a new interface for scientific computing. These agents can read papers, write code, generate hypotheses, call APIs, inspect files, and iterate on results. But science isn’…